Harvard Bioscience
HBIO
#8831
Rank
NZ$0.15 B
Marketcap
$3.64
Share price
-1.04%
Change (1 day)
-47.86%
Change (1 year)

Market capitalization of Harvard Bioscience (HBIO)

Market cap: NZ$0.15 Billion

As of November 2024 Harvard Bioscience has a market cap of NZ$0.15 Billion. This makes Harvard Bioscience the world's 8831th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Harvard Bioscience from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.15 B-56.01%
2023NZ$0.36 B98.7%
2022NZ$0.18 B-57.2%
2021NZ$0.42 B81.24%
2020NZ$0.23 B35.48%
2019NZ$0.17 B-2.4%
2018NZ$0.17 B9.34%
2017NZ$0.16 B7.08%
2016NZ$0.15 B-12.14%
2015NZ$0.17 B-26.89%
2014NZ$0.23 B30.22%
2013NZ$0.18 B15.69%
2012NZ$0.15 B10.69%
2011NZ$0.14 B-5.62%
2010NZ$0.14 B2.97%
2009NZ$0.14 B3.6%
2008NZ$0.14 B-23.91%
2007NZ$0.18 B-17.59%
2006NZ$0.22 B12.87%
2005NZ$0.19 B0.57%
2004NZ$0.19 B-52.2%
2003NZ$0.41 B118%
2002NZ$0.18 B-70.37%
2001NZ$0.63 B15.64%
2000NZ$0.55 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Harvard Bioscience was reported to be:

NZ$0.16 Billion
by Nasdaq info icon info icon
NZ$0.16 Billion
by CompaniesMarketCap info icon info icon